Acadian Asset Management
PLXP

Acadian Asset Management’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Acadian Asset Management’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-260
Closed -$3K – 1648
2017
Q1 		$3K Hold
260
– – ﹤0.01% 1507
2016
Q4 		$3K Buy
+260
New +$9.55K ﹤0.01% 1554

Other funds holding PLXP

PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
HWA
Heritage Way Advisors Rockford, Illinois $267M AUM 23.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Acadian Asset Management's PLXP Position: Q2 2017 in Review

Acadian Asset Management sold out of PLx Pharma Inc. Common Stock (PLXP) in Q2 2017, closing a stake of 260 shares — an estimated $3K sold.

Acadian Asset Management first reported a position in PLXP in Q4 2016 and held it in 2 quarters. The position peaked at $3K in Q1 2017. 14 funds tracked by Wall St. Rank hold PLXP as of Q2 2017.

  • Acadian Asset Management reported no remaining PLx Pharma Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
  • Acadian Asset Management sold 260 PLx Pharma Inc. Common Stock shares in Q2 2017, an estimated $3K.
  • Acadian Asset Management first reported a position in PLx Pharma Inc. Common Stock in Q4 2016 and held it in 2 quarters.
  • Acadian Asset Management's PLx Pharma Inc. Common Stock position peaked at $3K in Q1 2017.
  • 14 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q2 2017.

Based on Acadian Asset Management's 13F filing for Q2 2017, filed 25 Jul 2017.